Drug
Cardiovascular Fixed Dose Combination Pill
Cardiovascular Fixed Dose Combination Pill: highest development phase Phase 2, developed by Ferrer. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Ferrer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril) NCT01362218 | Phase 2 | Elevated LDL Cholesterol |
| Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril), NCT01004705 | Phase 2 | Elevated LDL Cholesterol |
Latest
No recent events.
Follow Cardiovascular Fixed Dose Combination Pill on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.